344 related articles for article (PubMed ID: 28539074)
1. Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians.
Sriram KB; Cox AJ; Clancy RL; Slack MPE; Cripps AW
Crit Rev Microbiol; 2018 Mar; 44(2):125-142. PubMed ID: 28539074
[TBL] [Abstract][Full Text] [Related]
2. Why we need a vaccine for non-typeable Haemophilus influenzae.
Cerquetti M; Giufrè M
Hum Vaccin Immunother; 2016 Sep; 12(9):2357-61. PubMed ID: 27171854
[TBL] [Abstract][Full Text] [Related]
3. The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable
Su YC; Jalalvand F; Thegerström J; Riesbeck K
Front Immunol; 2018; 9():2530. PubMed ID: 30455693
[TBL] [Abstract][Full Text] [Related]
4. Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.
Ahearn CP; Gallo MC; Murphy TF
Pathog Dis; 2017 Jun; 75(4):. PubMed ID: 28449098
[TBL] [Abstract][Full Text] [Related]
5. Changes in IgA Protease Expression Are Conferred by Changes in Genomes during Persistent Infection by Nontypeable Haemophilus influenzae in Chronic Obstructive Pulmonary Disease.
Gallo MC; Kirkham C; Eng S; Bebawee RS; Kong Y; Pettigrew MM; Tettelin H; Murphy TF
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760213
[TBL] [Abstract][Full Text] [Related]
6. Lung mucosal immunity to NTHi vaccine antigens: Antibodies in sputum of chronic obstructive pulmonary disease patients.
Baffetta F; Buonsanti C; Moraschini L; Aprea S; Canè M; Lombardi S; Contorni M; Rondini S; Arora AK; Bardelli M; Finco O; Serruto D; Paccani SR
Hum Vaccin Immunother; 2024 Dec; 20(1):2343544. PubMed ID: 38655676
[TBL] [Abstract][Full Text] [Related]
7. Understanding nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease.
Alikhan MM; Lee FE
Curr Opin Pulm Med; 2014 Mar; 20(2):159-64. PubMed ID: 24441573
[TBL] [Abstract][Full Text] [Related]
8. Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae.
Khan MN; Ren D; Kaur R; Basha S; Zagursky R; Pichichero ME
Expert Rev Vaccines; 2016 Jul; 15(7):863-78. PubMed ID: 26894630
[TBL] [Abstract][Full Text] [Related]
9. Adaptation of Nontypeable
Murphy TF; Kirkham C; D'Mello A; Sethi S; Pettigrew MM; Tettelin H
mBio; 2023 Apr; 14(2):e0014023. PubMed ID: 36927061
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae.
Euba B; López-López N; Rodríguez-Arce I; Fernández-Calvet A; Barberán M; Caturla N; Martí S; Díez-Martínez R; Garmendia J
Sci Rep; 2017 Oct; 7(1):12860. PubMed ID: 29038519
[TBL] [Abstract][Full Text] [Related]
11. Role of nontypeable Haemophilus influenzae in otitis media and chronic obstructive pulmonary disease.
Thanavala Y; Lugade AA
Adv Otorhinolaryngol; 2011; 72():170-5. PubMed ID: 21865721
[TBL] [Abstract][Full Text] [Related]
12. Relationships between Mucosal Antibodies, Non-Typeable Haemophilus influenzae (NTHi) Infection and Airway Inflammation in COPD.
Staples KJ; Taylor S; Thomas S; Leung S; Cox K; Pascal TG; Ostridge K; Welch L; Tuck AC; Clarke SC; Gorringe A; Wilkinson TM
PLoS One; 2016; 11(11):e0167250. PubMed ID: 27898728
[TBL] [Abstract][Full Text] [Related]
13. Antagonistic Pleiotropy in the Bifunctional Surface Protein FadL (OmpP1) during Adaptation of Haemophilus influenzae to Chronic Lung Infection Associated with Chronic Obstructive Pulmonary Disease.
Moleres J; Fernández-Calvet A; Ehrlich RL; Martí S; Pérez-Regidor L; Euba B; Rodríguez-Arce I; Balashov S; Cuevas E; Liñares J; Ardanuy C; Martín-Santamaría S; Ehrlich GD; Mell JC; Garmendia J
mBio; 2018 Sep; 9(5):. PubMed ID: 30254117
[TBL] [Abstract][Full Text] [Related]
14. Whole-genome analyses reveal gene content differences between nontypeable
Kc R; Leong KWC; Harkness NM; Lachowicz J; Gautam SS; Cooley LA; McEwan B; Petrovski S; Karupiah G; O'Toole RF
Microb Genom; 2020 Aug; 6(8):. PubMed ID: 32706329
[TBL] [Abstract][Full Text] [Related]
15. Recognition of conserved antigens by Th17 cells provides broad protection against pulmonary
Li W; Zhang X; Yang Y; Yin Q; Wang Y; Li Y; Wang C; Wong SM; Wang Y; Goldfine H; Akerley BJ; Shen H
Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7149-E7157. PubMed ID: 29987031
[TBL] [Abstract][Full Text] [Related]
16. Intranasal coinfection model allows for assessment of protein vaccines against nontypeable Haemophilus influenzae in mice.
Michel LV; Kaur R; Zavorin M; Pryharski K; Khan MN; LaClair C; O'Neil M; Xu Q; Pichichero ME
J Med Microbiol; 2018 Oct; 67(10):1527-1532. PubMed ID: 30136923
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin Pharmacodynamics against Persistent Haemophilus influenzae in Chronic Obstructive Pulmonary Disease.
Tsuji BT; Fisher J; Boadi-Yeboah R; Holden PN; Sethi S; Pettigrew MM; Murphy TF
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29180527
[TBL] [Abstract][Full Text] [Related]
18.
Pettigrew MM; Ahearn CP; Gent JF; Kong Y; Gallo MC; Munro JB; D'Mello A; Sethi S; Tettelin H; Murphy TF
Proc Natl Acad Sci U S A; 2018 Apr; 115(14):E3256-E3265. PubMed ID: 29555745
[TBL] [Abstract][Full Text] [Related]
19. Role of nontypeable Haemophilus influenzae in exacerbations and progression of chronic obstructive pulmonary disease.
Eldika N; Sethi S
Curr Opin Pulm Med; 2006 Mar; 12(2):118-24. PubMed ID: 16456381
[TBL] [Abstract][Full Text] [Related]
20. Unraveling Haemophilus influenzae virulence mechanisms enable discovery of new targets for antimicrobials and vaccines.
Langereis JD; de Jonge MI
Curr Opin Infect Dis; 2020 Jun; 33(3):231-237. PubMed ID: 32304471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
